Cassava Sciences raises over $125M from warrant distribution
Seeking Alpha News (Wed, 8-May 1:20 PM ET)
Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution
Globe Newswire (Wed, 8-May 11:00 AM ET)
Earnings week ahead: Disney, Palantir, Shopify, Uber, Plug Power and more
Seeking Alpha News (Sun, 5-May 8:00 AM ET)
Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
Globe Newswire (Wed, 1-May 9:10 AM ET)
Redemption Date Announced for Warrants
Globe Newswire (Mon, 15-Apr 9:20 AM ET)
Globe Newswire (Fri, 5-Apr 6:00 AM ET)
Globe Newswire (Tue, 2-Apr 10:20 AM ET)
Globe Newswire (Mon, 1-Apr 3:40 PM ET)
Globe Newswire (Sun, 31-Mar 3:07 PM ET)
Globe Newswire (Sun, 31-Mar 12:13 PM ET)
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
Cassava Sciences trades on the NASDAQ stock market under the symbol SAVA.
As of May 8, 2024, SAVA stock price declined to $21.74 with 889,012 million shares trading.
SAVA has a beta of 1.07, meaning it tends to be more sensitive to market movements. SAVA has a correlation of 0.03 to the broad based SPY ETF.
SAVA has a market cap of $940.16 million. This is considered a Small Cap stock.
In the last 3 years, SAVA stock traded as high as $146.16 and as low as $12.32.
The top ETF exchange traded funds that SAVA belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.
SAVA has underperformed the market in the last year with a return of -2.6%, while the SPY ETF gained +27.0%. In the last 3 month period, SAVA fell short of the market, returning -14.4%, while SPY returned +4.1%. However, in the most recent 2 weeks SAVA has outperformed the stock market by returning +5.8%, while SPY returned +2.3%.
SAVA support price is $20.74 and resistance is $22.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SAVA stock will trade within this expected range on the day.